Abstract
This paper challenges traditional views which oppose health economics and medical ethics by arguing that economic assessment is a necessary complement to medical ethics and can help to improve public participation and democratic processes in choices about resource allocation for health care technologies. In support of this argument, four points are emphasized: (1) Most current biomedical ethical debates implicitly deal with economic issues of resource allocation. (2) Clinical decisions, which usually respect the Hippocratic code of ethics, are nevertheless influenced by economic incentives and constraints. (3) Economic assessment is concerned with both efficiency and equity and potential trade-offs between the two, which means that ethical judgements are always embedded in welfare economics. (4) The real debate is not between economics on the one side and medical ethics on the other. Rather it is between different ethical conceptions of social justice and the contrasting approaches they entail to reconciling individual interests and preferences with collective goods and welfare.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arrow, K. (1963) Uncertainty and the Welfare Economics of Medical Care. American Economic Review 5, 941–973.
Auquier, P., Macquart-Moulin, G., Moatti J.P. et al. (1995) Comparison of Anxiety, Pain and Discomfort in Two Procedures of Hematopoietic Stem Cell Collection: Leukacytapheresis and Bone Marrow Harvest. Bone Marrow Transplantation 16, 541–547.
Culyer, A.J. (1989). The Normative Economics of Health Care Finance and Provision. Oxford Review of Economic Policy 5, 34–58.
Evans, R.G. (1974). Supplier-Induced Demand: Some Empirical Evidence and Implications. In M. Perlman (Ed.), The Economics of Health and Medical Care. Amsterdam: North-Holland.
Fleck, L.M. (1994). Just Caring: Oregon, Health Care Rationing and Informed Democratic Deliberation. Journal of Medical Philosophy 19, 367–388.
Harris, J. (1977). The Internal Organization of Hospitals: Some Economic Implications. Bell Journal of Economics 8, 467–482.
Hartmann, O., Le Ccoroller, A.G., Blaise, D. et al. (1997). Peripheral Blood Stem Cell and Bone Marrow Transplantation for Solid Tumors and Lymphomas: Hematologic Recovery and Costs. Annals of Internal Medicine 126, 600–607.
Haut Comite de la Sante Publique, 1998. Regional Allocation of Resources and Inequities in Health (in french). Paris: Ministère de la Santé.
Hillner, B.E., Smith T.J. and Desch, C.E. (1993). Assessing the Cost-effectiveness of Adjuvant Therapies in Breast Cancer Using Decision Analysis Model. Breast Cancer Research and Treatment 25, 97–105.
Jones-Lee, M.W. (Ed). (1982). The Value of Life and Safety. Amsterdam: North Holland.
Kaldor, N. (1939). Welfare Propositions of Economic and Interpersonal Comparisons of Utility. Economic Journal 49, 549–552.
Little, I.M.D. (1957). A Critique of Welfare Economics. Oxford: Oxford University Press.
Macbeth, H.M. (Ed.) (1996). Health Outcomes. Oxford: Oxford Science Publications.
Macquart-Moulin, G., Viens, P., Bouscary, M.L. et al. (1997). Discordance between Physicians' Estimations and Breast Cancer Patients Self-assessment of Side-effects of Chemotherapy: An Issue for Quality of Care. British Journal of Cancer 76, 1640–1645.
Mooney, G., Hall, J., Donaldson, C and Gerard, K. (1991). Utilisation as a Measure of Equity: Weighing Heat? Journal of Health Economics 10, 383–476.
Neumann, P.J. and Weinstein, M.C. (1991). The Diffusion of New Technology: Costs and Benefits to Health Care. In Gelinjs, A.C. and Halm, E.A. (Eds.), The Changing Economics of Medical Technology. Washington DC: National Academy Press.
Polaniyi, K. (1957). The Great Transformation: The Political and Economic Origins of Our Time. Boston: Beacon Press.
Protiere, C., Genre, D., Cowen, D. et al. (1997). Elicitation of Preferences and Breast Cancer: Patients' Participation in the Decision-Making Process. European Journal of Cancer 33, S9.
Redelmeier, D.A. and Tversky, A. (1990). Discrepancy Between Medical Decisions for Individual Patients and for Groups. New England Journal Of Medicine 322, 1162–1164.
Rifkin, J. (1998). The Biotech Century: Harnessing the Gene and Remaking the World. New-York: Tarcher & Putnam's Sons.
Rotily, M., Loubiere, S., Nixon, J., Bourliere, M., Halfon, P. and Moatti, J.P. (1997). Socio-Economic Analysis of Various Screening Strategies for Chronic Hepatitis C in a French Population. Gastroentérologie Biologique & Clinique 20, S33–S40.
Sen, A.K. (1974). Rawls versus Bentham: An Axiomatic Examination of the Pure Distribution Problem. Theory and Decision 4, 132–157.
Tobin, J. (1970). Limiting the Domain of Inequality. Journal of Law and Economics 13, 263–277.
Tonnaire, G., Paraponaris, A., Chanut, C. and Sambuc, R. (1997). Institutional Structure, Financing Mechanisms and Heterogeneity in Cancer Supply: Experience from 1,078 Breast Cancer Patients in a French Region. European Journal of Cancer 33, S12.
Udvarheliyi, L.S., Colditz, R.A., Rai, A. and Epstein, A.M. (1991). Cost-Effectiveness and Cost-Benefit Analyses in the Medical Literature. Are the Methods Being Used Correctly? Annals of Internal Medicine 116, 238–244.
Van Doorslaeer, E., Wagstaff, A. and Rutten, F. (Eds).(1993). Equity in the Finance and Delivery of Health Care. An International Perspective. Oxford: Oxford Medical Publications.
Warnock, M. (1994). Some Moral Problems in Medicine. Health Economics 3, 297–300.
Warnock, M. (1998). An Intelligent Person's Guide to Ethics. London: Duckworth & Co. Ltd.
Wennberg, J.E. and Gittelshon, A. (1982). Variation in Medical Care among Small Areas. Scientific American 246, 100–112.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moatti, JP. Ethical Issues in the Economic Assessment of Health Care Technologies. Health Care Analysis 7, 153–165 (1999). https://doi.org/10.1023/A:1009437104347
Issue Date:
DOI: https://doi.org/10.1023/A:1009437104347